IL-6 in the Cerebrospinal Fluid Signals Disease Activity in Multiple Sclerosis-Reference-Cited by-同舟云学术

IL-6 in the Cerebrospinal Fluid Signals Disease Activity in Multiple Sclerosis

Published:2020-06-23 Issue: Volume:14 Page:
ISSN:1662-5102
Container-title:Frontiers in Cellular Neuroscience
language:
Short-container-title:Front. Cell. Neurosci.

Author:

Stampanoni Bassi Mario,Iezzi Ennio,Drulovic Jelena,Pekmezovic Tatjana,Gilio Luana,Furlan Roberto,Finardi Annamaria,Marfia Girolama Alessandra,Sica Francesco,Centonze Diego,Buttari Fabio

Funder

Fondazione Italiana Sclerosi Multipla

Publisher

Frontiers Media SA

Subject

Cellular and Molecular Neuroscience

Reference32 articles.

1. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells;Bettelli;Nature,2006

2. Inflammation triggers synaptic alteration and degeneration in experimental autoimmune encephalomyelitis;Centonze;J. Neurosci.,2009

3. PDGFs protect hippocampal neurons against energy deprivation and oxidative injury: evidence for induction of antioxidant pathways;Cheng;J. Neurosci.,1995

4. Analysis of IL-6, IL-1β and TNF-α production in monocytes isolated from multiple sclerosis patients treated with disease modifying drugs;Fiedler;J. Syst. Integr. Neurosci.,2017

5. Cytokine signaling in multiple sclerosis: lost in translation;Göbel;Mult. Scler.,2018

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential prognostic value of rheumatoid factor in anti-aquaporin 4-immunoglobin G-positive neuromyelitis optica spectrum disorders;Journal of the Neurological Sciences;2024-11

2. An IL-5 Single-Nucleotide Polymorphism Influences Neuroinflammation and Prospective Disease Activity in Multiple Sclerosis;International Journal of Molecular Sciences;2024-08-22

3. Cytokine Profiling in Cerebrospinal Fluid of Patients with Newly Diagnosed Relapsing-Remitting Multiple Sclerosis (RRMS): Associations between Inflammatory Biomarkers and Disease Activity;International Journal of Molecular Sciences;2024-07-05

4. The impact of interleukin-6 (IL-6) and mesenchymal stem cell-derived IL-6 on neurological conditions;Frontiers in Immunology;2024-06-24

5. Immune System Dysregulation in the Progression of Multiple Sclerosis: Molecular Insights and Therapeutic Implications;Neuroscience;2024-06